RecruitingNot ApplicableNCT03527420

DNA Methylation and Vascular Function

DNA Methylation and Vascular Function in Obesity: Role of Exercise and Weight Loss


Sponsor

University of Illinois at Chicago

Enrollment

80 participants

Start Date

Oct 11, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The main objective is to examine DNA hypomethylation as an underlying mechanism for the increased production of inflammatory cytokines and the impaired vascular function in obese individuals and as a potential target for nonpharmacological preventive/therapeutic interventions such as aerobic exercise.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Exercise training for people with obesity and vascular dysfunction. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExercise training

Twelve weeks of aerobic exercise training


Locations(1)

University of Illinois at Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03527420


Related Trials